Friday, December 10, 2010

“Reportlinker Adds Industry Dynamics: 2010 Guide to the Asia-Pacific Life Sciences Industry - Yahoo Finance” plus 1 more

“Reportlinker Adds Industry Dynamics: 2010 Guide to the Asia-Pacific Life Sciences Industry - Yahoo Finance” plus 1 more


Reportlinker Adds Industry Dynamics: 2010 Guide to the Asia-Pacific Life Sciences Industry - Yahoo Finance

Posted: 09 Dec 2010 10:36 AM PST

Press Release Source: Reportlinker On Thursday December 9, 2010, 1:44 pm EST

NEW YORK, Dec. 9, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Industry Dynamics: 2010 Guide to the Asia-Pacific Life Sciences Industry

http://www.reportlinker.com/p0337467/Industry-Dynamics-2010-Guide-to-the-Asia-Pacific-Life-Sciences-Industry.html

Introduction

Pharmaceutical companies are expanding into the Asia-Pacific region to increase their market share and reduce costs. The life sciences industry is difficult enough for technology vendors to enter, but add to it the complexity of emerging markets, and the process can be downright overwhelming. Ovum provides an Introduction to the life sciences in APAC in order for vendors to penetrate the market.

Features and benefits

Offers an overview of the pharmaceutical and biotechnology sectors in Australia, China, India, and Japan

Discusses key areas where there is greatest need for technology in the APAC life sciences industry

Provides go-to-market strategies to help vendors enter the APAC pharma and biotech markets and realize successful

Highlights

Before attempting to penetrate the APAC pharma market, it is important to understand the complexity of the global life sciences industry. Once vendors understand the industry as a whole, they will better comprehend the dynamics of the APAC markets and how the developed and emerging pharma industries fit into their customers' global strategies.

The Asia-Pacific life sciences industry varies greatly, comprised of both developed and emerging markets. It is also home to small, emerging biotech companies with up to ten employees as well as Big Pharma with thousands of employees. As wide as the spectrum is for size and type of life sciences company, so is the need for IT solutions.

The emerging markets have seen tremendous growth, and this trend will likely continue, but not without the help of key IT solutions. The APAC pharma and biotech sectors are much more open to the use of IT that their Western counterparts, but it is still important for technology vendors to understand where and how to best realize success.

Your key questions answered

Understand the pharmaceutical and biotechnology product lifecycle and business processes

Identify emerging areas of concern for pharmaceutical and biotechnology companies, particularly in Australia, China, India and Japan

Gain insight into what solutions and services will appeal most to APAC life sciences companies

TABLE OF CONTENTS

SUMMARY 1

Catalyst 1

Ovum view 2

Key messages 3

Understanding the Pharma Process 8

About the industry 8

The drug discovery and development process is long and expensive 9

The biggest challenge facing the pharma industry is the successful navigation of the 2011 patent cliff 16

The APAC Life Sciences Market 19

Overview of APAC markets 19

Australia's pharmaceutical market 20

China's pharmaceutical market 21

India's pharmaceutical market 23

Japan's pharmaceutical market 25

Slowing growth in major developed markets drives pharma M&A in APAC 26

Trends within countries based on the process areas 27

Opportunities for Technology Vendors 32

How best to capitalize 32

The pharma product lifecycle plays a crucial role in IT strategy 32

IT engagement with pharma comes with its own set of dynamics 42

With no two life sciences markets exactly the same, neither is their IT investment 48

Recommendations for Technology Vendors 53

The right solutions for the right processes 53

Position technology along the pharma lifecycle 53

Know the pharma company's product pipeline and drug portfolio 54

Route to market will be a critical success factor 54

Keep in mind that IT budget allocation does not equal priority 55

Focus on IT solutions that enable the shift towards biotech research 56

APPENDIX 57

Definitions 57

Further reading 58

Methodology 59

Ovum authors 61

Datamonitor author 61

Ovum Consulting 62

Disclaimer 62

TABLE OF

FIGURES

Figure 1: The drug discovery and development lifecycle 9

Figure 2: The drug discovery and pre-clinical research processes 10

Figure 3: The clinical trials process 11

Figure 4: SCOR: Capturing the pharma manufacturing process 13

Figure 5: Stakeholders involved in pharma sales and marketing 14

Figure 6: The sales and marketing process through shelf-time 16

Figure 7: Loss in sales due to generic erosion from brands expiring between 2010 and 2014 17

Figure 8: Heat map of discovery and pre-clinical research activity in APAC 28

Figure 9: Heat map of clinical trial activity in APAC 29

Figure 10: Heat map of manufacturing activity in APAC 30

Figure 11: Heat map of sales and marketing activity in APAC 31

Figure 12: The pharma business processes and associated IT solutions 33

Figure 13: Heat map of research IT adoption in APAC over five years 35

Figure 14: Heat map of clinical research IT adoption in APAC over five years 36

Figure 15: Heat map of manufacturing IT adoption in APAC over five years 38

Figure 16: Heat map of sales and marketing IT adoption in APAC over five years 41

Figure 17: Percentage of IT budget allocated to various technology solutions 42

Figure 18: Pharma IT budget allocations by technology category 44

Figure 19: Cloud computing adoption plans in pharma companies 46

Figure 20: Influence of C-level executives on IT investment 47

Figure 21: Australia's IT spending by life sciences sector, 2009-2015 49

Figure 22: China's IT spending by life sciences sector, 2009-2015 50

Figure 23: India's IT spending by life sciences sector, 2009-2015 51

Figure 24: Japan's IT spending by life sciences sector, 2009-2015 52

Figure 25: Priority of technology solution for IT budget allocation 55

TABLE OF

TABLES

Table 1: Pharmaceutical and biotechnology industry sub-segments 8

Table 2: Key population, healthcare expenditure and pharmaceutical and biotechnology market indicators for APAC 19

Table 3: Sales growth for the leading pharmaceutical and biotechnology companies in APAC, 2005–9 20

To order this report:

Healthcare Industry: Industry Dynamics: 2010 Guide to the Asia-Pacific Life Sciences Industry

Healthcare Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!


CONTACT:  

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


This entry passed through the Full-Text RSS service — if this is your content and you're reading it on someone else's site, please read our FAQ page at fivefilters.org/content-only/faq.php
Five Filters featured site: So, Why is Wikileaks a Good Thing Again?.

The Arboretum's new I-Map is a customizable guide - Isthmus Daily Page

Posted: 09 Dec 2010 10:03 PM PST

Its capacity, potential and versatility are evident from the moment you log on to the UW Arboretum's new interactive map (uwarboretum.org/map). Still in its infancy following its November debut, it is already loaded with so many features that even the most jaded Arboretum visitor may discover something new.

The "Learn" tab alone allows I-Map users to choose from base maps charting the Arboretum's ecological communities, its terrain or an aerial view. Over these, you can lay an abundance of data. One layer displays the sanctuary's trail network, another its wetlands, still others its featured restoration projects, its effigy mounds, its springs and so on. Depending on the strata you select, scrolling your mouse over the I-Map may yield historical primers on Lost City or the old Civilian Conservation Corps camp; notes on the distinctive properties of different silt or sandy loams; a complete inventory of trees in Longenecker Gardens; aerial views of the property from 1937 and 1962; birding hot spots; images of fauna captured by wildlife research cameras; even the boundaries for the Arb's watersheds, which include the Mendota and Monona basins as well as Wingra, plus Badger Mill and Nine Springs creeks.

Mark Wegener, a database technician for the Arboretum, is a principal architect of the map, produced in collaboration with the UW Cartography Lab and the private Axis Maps LLC and drawn from the vast Geographic Information System database Wegener manages for the 1,260-acre research sanctuary.

Wegener says one of the map's principal audiences will be researchers who need to know as much as possible about soils, hydrology and other factors key to siting their projects. But he expects the broadest audience to include visitors who seek a deeper understanding of the Arboretum. Wegener also hopes the resource will help recruit a younger, computer-savvy generation of Arboretum visitors to succeed the devoted but aging constituency of existing donors and volunteers.

"We struggle a bit," he explains, "because we're a natural area in the middle of the city." Some area residents may know about the Arboretum, he notes, but not its research functions.

These are suggested by the Arboretum's litany of rules: no dogs, stay on the trails, no off-road biking, no Rollerblades, no loud music, etc. One of the I-Map's aims, Wegener says, is to "creatively communicate" Arboretum research "so people don't just assume that we're a park that has a lot of rules."

The new map is still being optimized as glitches are addressed. Chief among the early complaints Wegener has heard are that parts of the map are too small to be legible (a fault easily corrected with the map's +/- tool, explained in the site's introductory tutorial video) and that the density of its data layers can sometimes render performance sluggish on slower Internet connections.

"We wanted to build this thing to be robust," Wegener explains, so it could evolve and adapt to new ideas and needs. Such mutability is a hallmark of interactive maps that aspire to lure users back for repeat visits.

He expects further refinements to be driven by user feedback but also tantalizing possibilities like those posed by a six-foot map cabinet "full of all these awesome paper maps going back to the 1930s," some hand-drawn by the likes of legendary environmentalist Aldo Leopold.

So vast is the Arboretum's Geographic Information System database that to add everything to the I-Map might be prohibitive, Wegener allows, but more features are under consideration. Among them: a hike of the month and the conversion of Curtis Prairie census archives into an animation illustrating species diversity and migration across the decades.

Wegener's own favorites among the I-Map's existing features include a tool that allows hikers, runners and Nordic skiers to calculate trail distances for their routes. He also likes the tab labeled Your Turn, where visitors can post their own Arboretum photos and observations as a complement to features like Arboretum naturalists' notes.

"You kind of have your own idea of what people like about the Arboretum," he explains. "I think it's neat to see other people's view" by inviting input from "the people appreciating the place and using it."

This entry passed through the Full-Text RSS service — if this is your content and you're reading it on someone else's site, please read our FAQ page at fivefilters.org/content-only/faq.php
Five Filters featured site: So, Why is Wikileaks a Good Thing Again?.

0 comments:

Post a Comment